Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Mouse Models of Cancer Study02:43

Mouse Models of Cancer Study

Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
Mouse Models of Cancer Study02:43

Mouse Models of Cancer Study

Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Inhibition of PERK signaling suppresses tumor progression and blocks GP73-GRP78-dependent stromal activation in hepatocellular carcinoma.

Neoplasia (New York, N.Y.)·2026
Same author

Interleukin-8-Driven Monocyte Activation in Primary Sclerosing Cholangitis: Insights from Single-Cell Analysis and Humanized Immune System Mice.

JHEP reports : innovation in hepatology·2026
Same author

Plasma cell-free transcriptome profiling in blood plasma from chronic liver disease patients.

Scientific data·2026
Same author

Prevalence of gastrointestinal side effects in hepatocellular carcinoma patients receiving sorafenib: a meta-analysis of 136 studies and 14,416 patients.

Therapeutic advances in medical oncology·2026
Same author

Impeding hypoxia-driven tumor progression in hepatocellular carcinoma: clinical and pre-clinical analyses using 2D and 3D in vitro models.

Biology direct·2026
Same author

Pharmacological inhibition of the PERK pathway modulates hepatocellular carcinoma growth and immune signaling.

FEBS open bio·2026

Related Experiment Video

Updated: Jun 21, 2026

An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis
06:38

An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis

Published on: September 12, 2019

Experimental mouse models for hepatocellular carcinoma research.

Femke Heindryckx1, Isabelle Colle, Hans Van Vlierberghe

  • 1Department of Gastroenterology and Hepatology, Ghent University Hospital, 9000 Ghent, Belgium. femke.heindryckx@ugent.be

International Journal of Experimental Pathology
|August 8, 2009
PubMed
Summary

This review examines mouse models for hepatocellular carcinoma (HCC) research, detailing chemically induced, xenograft, and genetically modified approaches. Understanding these models aids in developing new treatments for liver cancer.

More Related Videos

Extended 78% Hepatectomy in a Mouse Surgical Model
05:25

Extended 78% Hepatectomy in a Mouse Surgical Model

Published on: May 24, 2024

A "Patient-Like" Orthotopic Syngeneic Mouse Model of Hepatocellular Carcinoma Metastasis
05:06

A "Patient-Like" Orthotopic Syngeneic Mouse Model of Hepatocellular Carcinoma Metastasis

Published on: October 24, 2015

Related Experiment Videos

Last Updated: Jun 21, 2026

An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis
06:38

An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis

Published on: September 12, 2019

Extended 78% Hepatectomy in a Mouse Surgical Model
05:25

Extended 78% Hepatectomy in a Mouse Surgical Model

Published on: May 24, 2024

A "Patient-Like" Orthotopic Syngeneic Mouse Model of Hepatocellular Carcinoma Metastasis
05:06

A "Patient-Like" Orthotopic Syngeneic Mouse Model of Hepatocellular Carcinoma Metastasis

Published on: October 24, 2015

Area of Science:

  • Hepatocellular Carcinoma (HCC) Research
  • Animal Models in Oncology
  • Liver Cancer Pathogenesis

Background:

  • Hepatocellular carcinoma (HCC) affects nearly 500,000 new patients annually, presenting a significant global health challenge with a poor prognosis.
  • Effective experimental models are crucial for understanding HCC pathogenesis and evaluating new therapeutic agents.
  • Current research relies on various animal models to investigate liver cancer development and treatment strategies.

Purpose of the Study:

  • To review and analyze the advantages and limitations of different mouse models used in hepatocellular carcinoma (HCC) research.
  • To provide insights into the utility of chemically induced, xenograft, and genetically modified mouse models for HCC studies.
  • To guide researchers in selecting appropriate models for investigating HCC pathogenesis and drug development.

Main Methods:

  • Analysis of chemically induced HCC mouse models, involving genotoxic compounds to mimic the injury-fibrosis-malignancy cycle.
  • Evaluation of xenograft models, where hepatoma cell lines are implanted (ectopically or orthotopically) for drug screening.
  • Review of genetically modified mouse models, including transgenic mice expressing viral genes, oncogenes, or growth factors to study hepatocarcinogenesis pathways.
  • Consideration of the hollow fiber assay as a method to reduce animal numbers in xenograft studies.

Main Results:

  • Chemically induced models effectively replicate the HCC injury-fibrosis-malignancy sequence.
  • Xenograft models are valuable for drug screening, but require careful interpretation due to cell line variability.
  • Genetically modified models, particularly transgenic mice, are instrumental in identifying key pathways in liver cancer development.
  • The hollow fiber assay presents a strategy for optimizing xenograft research efficiency.

Conclusions:

  • Various mouse models offer distinct advantages for studying hepatocellular carcinoma (HCC) at different research stages.
  • Chemically induced, xenograft, and genetically modified models each provide unique insights into HCC pathogenesis and therapeutic potential.
  • Careful selection and application of these models are essential for advancing HCC research and improving patient outcomes.